Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-19

FDA Approved: SOMAVERT — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

FDA approved a supplemental application for Somavert (pegvisomant) submitted by Pharmacia & Upjohn Company LLC. Somavert is used to treat acromegaly due to exce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somavert (pegvisomant)

Snippet

SUPPL AP for SOMAVERT (PEGVISOMANT)